Medical experts say vaccination is the best prevention method for hepatitis B, a liver infection that can be acute or chronic ...

Multibillion-dollar worldwide market for HBV is driving race to a cure. ContraVir’s success with combination drugs would revolutionize HBV therapy. Standard risks apply, including possible trouble in ...

RNAi is a revolutionary and powerful biotech modality that is being utilized for Chronic Hepatitis B. Investors should heed caution as RNAi has been plagued by clinical failures and setbacks. RNAi has ...

The Phase II study AB-10-8008 focuses on treatment-naïve CHB participants in a randomised, multicentre design.

It's unusual for presidents to give medical advice. But this week, President Trump told parents to delay giving their kids a ...

The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window While hepatitis ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window VIENNA – The ...

A new approach for discovering antivirals against hepatitis B and E viruses aims to identify new drug candidates for these life-threatening diseases. Building on his lab’s expertise in human liver ...

Hepatitis B (HBV) is a viral infection that affects the liver by causing inflammation. This can lead to permanent scarring, what medical professionals call liver fibrosis or cirrhosis. Most hepatitis ...